Nocturnal polyuria: Literature review of definition,pathophysiology,investigations and treatment

Abstract

Nocturnal polyuria (NP) is characterised by increased urine production overnight in comparison to daytime. It has significant adverse events in adults including reduced quality of life, increased risk of falls and increased mortality.

Although NP can be a manifestation of other significant conditions like heart failure and sleep apnoea, there are lots of unanswered questions about NP. What is the underlying pathophysiology? Is NP a physiological manifestation of ageing? Is the circadian change of vasopressin release the primary pathology? Or is it a secondary phenomenon to a low diurnal production of urine? Is the primary pathology at the kidney level or is there another humoral, cardiac, or endovascular element? In this article, we summarise the available English-language literature on the subject of NP, including its epidemiology, pathogenesis, diagnosis and treatment.

Level of evidence: Not applicable for this multicentre audit.

Keywords

Desmopressin diabetes heart failure nocturia nocturnal polyuria sleep apnoea

Get full access to this article

View all access options for this article.

References

Umlauf

Chasens

ER.

Sleep disordered breathing and nocturnal polyuria: Nocturia and enuresis. Sleep Med Rev 2003; 7: 403–411.

Bosch

Everaert

Weiss

et al . Would a new definition and classification of nocturia and nocturnal polyuria improve our management of patients? ICI-RS 2014. Neurourol Urodyn 2016; 35: 283–287.

Abrams

Cardozo

Fall

et al . The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–178.

Kirkland

Lye

Levy

et al . Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J (Clin Res Ed) 1983; 287: 1665–1667.

Blanker

Bernsen

Bosch

et al . Relation between nocturnal voiding frequency and nocturnal urine production in older men: A population-based study. Urology 2002; 60: 612–616.

Goessaert

Walle

Bosch

et al . Nocturnal polyuria: Excess of nocturnal urine production, excess of definitions – influence on renal function profile. J Urol 2016; 195: 670–676.

van Haarst

Bosch

. A cutoff value based on analysis of a reference population decreases overestimation of the prevalence of nocturnal polyuria. J Urol 2012; 188: 869–873.

Bray

GA.

Overweight is risking fate. Definition, classification, prevalence, and risks. Ann N Y Acad Sci 1987; 499: 14–28.

Mander

Winer

Walker

MP.

Sleep and human aging. Neuron 2017; 94: 19–36.

10.

Rembratt

Norgaard

Andersson

KE.

What is nocturnal polyuria?

BJU Int 2002; 90 (Suppl 3): 18–20.

11.

Robertson

Rittig

Kovacs

et al . Pathophysiology and treatment of enuresis in adults. Scand J Urol Nephrol Suppl 1999; 202: 36–38; discussion 38–39.

12.

Weiss

van Kerrebroeck

Klein

et al . Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. J Urol 2011; 186: 1358–1363.

13.

van Doorn

Blanker

Kok

et al . Prevalence, incidence, and resolution of nocturnal polyuria in a longitudinal community-based study in older men: The Krimpen study. Eur Urol 2013; 63: 542–547.

14.

Weiss

Blaivas

JG.

Nocturia. J Urol 2000; 163: 5–12.

15.

Koseoglu

Aslan

Ozdemir

et al . Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology 2006; 67: 1188–1192.

16.

Rittig

Knudsen

Norgaard

et al . Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 1989; 256 (4 Pt 2): F664–F671.

17.

Neveus

Hansell

Stenberg

Vasopressin and hypercalciuria in enuresis: A reappraisal. BJU Int 2002; 90: 725–729.

18.

Natsume

Diuretic pattern in adults with nocturnal polyuria: The possible contribution of blood pressure to the worsening of nocturnal polyuria. Int J Urol 2007; 14: 822–827.

19.

Tani

Hirayama

Fujimoto

et al . Increase in 24-hour urine production/weight causes nocturnal polyuria due to impaired function of antidiuretic hormone in elderly men. Int J Urol 2008; 15: 151–154; discussion 155.

20.

De Guchtenaere

Vande Walle

Van Sintjan

et al . Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning. J Urol 2007; 178: 2635–2639; discussion 2639.

21.

Marples

Christensen

et al . Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 1995; 95: 1838–1845.

22.

Leal

Elias

Moreira

AC.

Impairment of AVP regulation in 17alpha-hydroxylase deficiency, a unique form of adrenal insufficiency. J Endocrinol Invest 2002; 25: 635–638.

23.

Verbalis

JG.

Renal physiology of nocturia. Neurourol Urodyn 2014; 33 (Suppl 1): S6–S9.

24.

Goessaert

Krott

Hoebeke

et al . Diagnosing the pathophysiologic mechanisms of nocturnal polyuria. Eur Urol 2015; 67: 283–288.

25.

Van Kerrebroeck

Andersson

. Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn 2014; 33 (Suppl 1): S2–S5.

26.

Dehoorne

Raes

van Laecke

et al . Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion. J Urol 2006; 176: 749–753.

27.

Weiss

Bosch

Drake

et al . Nocturia Think Tank: Focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn 2012; 31: 330–339.

28.

Longo

Fauci

Kasper

et al . (eds) Harrison’s™ principles of internal medicine. 18th ed. New York: McGraw-Hill, 2011.

29.

Torimoto

Hirayama

Samma

et al . The relationship between nocturnal polyuria and the distribution of body fluid: Assessment by bioelectric impedance analysis. J Urol 2009; 181: 219–224; discussion 224.

30.

Hirayama

Torimoto

Yamada

et al . Relationship between nocturnal urine volume, leg edema, and urinary antidiuretic hormone in older men. Urology 2011; 77: 1426–1431.

31.

Gulur

Mevcha

Drake

MJ.

Nocturia as a manifestation of systemic disease. BJU Int 2011; 107: 702–713.

32.

Akiyama

Hirayama

Fujimoto

et al . Cutoff value of urinary arginine vasopressin for nocturnal polyuria in elderly men. Urology 2007; 69: 98–102.

33.

Ohashi

Fujio

Nawata

et al . High plasma concentrations of human atrial natriuretic polypeptide in aged men. J Clin Endocrinol Metab 1987; 64: 81–85.

34.

Bichet

DG.

Vasopressin receptors in health and disease. Kidney Int 1996; 49: 1706–1711.

35.

Beck

LH.

The aging kidney. Defending a delicate balance of fluid and electrolytes. Geriatrics 2000; 55: 26–28, 31–32.

36.

Heinzer

Vat

Marques-Vidal

et al . Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study. Lancet Respir Med 2015; 3: 310–318.

37.

Chen

Wang

Zee

et al . Racial/Ethnic differences in sleep disturbances: The Multi-Ethnic Study of Atherosclerosis (MESA). Sleep 2015; 38: 877–888.

38.

Niimi

Suzuki

Yamaguchi

et al . Sleep apnea and circadian extracellular fluid change as independent factors for nocturnal polyuria. J Urol 2016; 196: 1183–1189.

39.

Moriyama

Miwa

Tanaka

et al . Nocturia in men less than 50 years of age may be associated with obstructive sleep apnea syndrome. Urology 2008; 71: 1096–1098.

40.

Yumino

Redolfi

Ruttanaumpawan

et al . Nocturnal rostral fluid shift: A unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121: 1598–1605.

41.

Kang

Yoon

Lee

et al . The impact of sleep apnoea syndrome on nocturia according to age in men. BJU Int 2012; 110 (11 Pt C): E851–E856.

42.

Yalkut

Lee

Grider

et al . Mechanism of atrial natriuretic peptide release with increased inspiratory resistance. J Lab Clin Med 1996; 128: 322–328.

43.

Witthaus

Nipa

Yang

et al . Bladder oxidative stress in sleep apnea contributes to detrusor instability and nocturia. J Urol 2015; 193: 1692–1699.

44.

Asplund

Diuresis pattern, plasma vasopressin and blood pressure in healthy elderly persons with nocturia and nocturnal polyuria. Neth J Med 2002; 60: 276–280.

45.

Matthiesen

Rittig

Norgaard

et al . Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol 1996; 156: 1292–1299.

46.

Robertson

Shelton

Athar

The osmoregulation of vasopressin. Kidney Int 1976; 10: 25–37.

47.

Kim

Yoon

et al . Nocturnal polyuria and decreased serum testosterone: Is there an association in men with lower urinary tract symptoms? Int J Urol 2014; 21: 518–523.

48.

Seaman

Jacobs

Blaivas

et al . Persistence or recurrence of symptoms after transurethral resection of the prostate: A urodynamic assessment. J Urol 1994; 152: 935–937.

49.

Platz

Smit

Curhan

et al . Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology 2002; 59: 877–883.

50.

Van Kerrebroeck

. Nocturia: Current status and future perspectives. Curr Opin Obstet Gynecol 2011; 23: 376–385.

51.

Kato

Hishida

Ishibashi

et al . Nephrogenic diabetes insipidus associated with bilateral ureteral obstruction. Intern Med 1994; 33: 231–233.

52.

Bae

Kim

et al . Desmopressin add-on therapy for refractory nocturia in men receiving alpha-blockers for lower urinary tract symptoms. J Urol 2013; 190: 180–186.

53.

Choi

et al . Change of nocturnal polyuria after holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia. Urology 2014; 84: 650–656.

54.

Cornu

Abrams

Chapple

et al . A contemporary assessment of nocturia: Definition, epidemiology, pathophysiology, and management – a systematic review and meta-analysis. Eur Urol 2012; 62: 877–890.

55.

Sia

Hong

Tan

LWL

et al . Awareness and knowledge of obstructive sleep apnea among the general population. Sleep Med 2017; 36: 10–17.

56.

Hirayama

Fujimoto

Akiyama

et al . Decrease in nocturnal urinary levels of arginine vasopressin in patients with nocturnal polyuria. Urology 2006; 68: 19–23.

57.

Johnson

2nd Miller

Pillion

et al . Arginine vasopressin and nocturnal polyuria in older adults with frequent nighttime voiding. J Urol 2003; 170 (2 Pt 1): 480–484.

58.

Tajima

Sagawa

Iwamoto

et al . Renal and endocrine responses in the elderly during head-out water immersion. Am J Physiol 1988; 254 (6 Pt 2): R977–R983.

59.

Kallas

Chintanadilok

Maruenda

et al . Treatment of nocturia in the elderly. Drugs Aging 1999; 15: 429–437.

60.

Lose

Lalos

Freeman

et al . Efficacy of desmopressin (Minirin) in the treatment of nocturia:A double-blind placebo-controlled study in women. Am J Obstet Gynecol 2003; 189: 1106–1113.

61.

Mattiasson

Abrams

Van Kerrebroeck

et al . Efficacy of desmopressin in the treatment of nocturia: A double-blind placebo-controlled study in men. BJU Int 2002; 89: 855–862.

62.

Wang

Lin

Huang

et al . Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: A double-blind, placebo controlled, randomized study. J Urol 2011; 185: 219–223.

63.

Chang

Lin

Chen

. Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria. J Urol 2007; 177: 2227–2230.

64.

Alsalameh

Burian

Mahr

et al . Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor. Aliment Pharmacol Ther 2003; 17: 489–501.

65.

Kinn

Elbarouni

Seideman

et al . The effect of diclofenac sodium on renal function. Scand J Urol Nephrol 1989; 23: 153–157.

66.

Kojima

Sasaki

Imura

et al . Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: A prospective open-label long-term study using frequency-volume chart. Neurourol Urodyn 2012; 31: 80–85.

67.

Simon

Everitt

van Dorp

et al . Oxford handbook of general practice. 4th ed. Oxford: Oxford University Press, 2014.

68.

Fujikawa

Kasahara

Matsui

et al . Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scand J Urol Nephrol 2001; 35: 310–313.